Creative Planning boosted its position in Adient plc (NYSE:ADNT – Free Report) by 138.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,708 shares of the company’s stock after buying an additional 21,291 shares during the quarter. Creative Planning’s holdings in Adient were worth $828,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of ADNT. CWM LLC boosted its stake in Adient by 44.5% in the second quarter. CWM LLC now owns 1,439 shares of the company’s stock valued at $36,000 after acquiring an additional 443 shares during the period. Covestor Ltd boosted its stake in Adient by 201.5% in the first quarter. Covestor Ltd now owns 3,307 shares of the company’s stock valued at $109,000 after acquiring an additional 2,210 shares during the period. Lazard Asset Management LLC acquired a new position in Adient in the first quarter valued at approximately $135,000. Headlands Technologies LLC acquired a new position in Adient in the first quarter valued at approximately $159,000. Finally, Algert Global LLC acquired a new position in Adient in the second quarter valued at approximately $227,000. 92.44% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have commented on ADNT shares. UBS Group decreased their target price on Adient from $27.00 to $24.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Morgan Stanley decreased their target price on Adient from $32.00 to $21.00 and set an “underweight” rating for the company in a research note on Wednesday, August 14th. JPMorgan Chase & Co. reduced their price objective on Adient from $31.00 to $27.00 and set a “neutral” rating for the company in a research report on Thursday, August 8th. Wolfe Research initiated coverage on Adient in a research report on Thursday, September 5th. They set a “peer perform” rating for the company. Finally, Barclays reduced their price objective on Adient from $29.00 to $24.00 and set an “equal weight” rating for the company in a research report on Thursday, August 8th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $25.38.
Adient Stock Performance
ADNT opened at $19.82 on Friday. The company has a market capitalization of $1.73 billion, a price-to-earnings ratio of 26.78, a price-to-earnings-growth ratio of 0.40 and a beta of 2.16. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.08 and a quick ratio of 0.87. Adient plc has a 1-year low of $19.40 and a 1-year high of $37.19. The business has a 50 day moving average price of $21.70 and a two-hundred day moving average price of $24.50.
Adient (NYSE:ADNT – Get Free Report) last released its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.30). The firm had revenue of $3.72 billion during the quarter, compared to analyst estimates of $3.82 billion. Adient had a return on equity of 6.34% and a net margin of 0.50%. The business’s revenue for the quarter was down 8.4% on a year-over-year basis. During the same quarter last year, the company earned $0.98 earnings per share. Research analysts predict that Adient plc will post 1.73 EPS for the current fiscal year.
Adient Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
See Also
- Five stocks we like better than Adient
- What is an Earnings Surprise?
- Battle of the Retailers: Who Comes Out on Top?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- 3 Small Caps With Big Return Potential
- MarketBeat Week in Review – 10/28 – 11/1
Want to see what other hedge funds are holding ADNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adient plc (NYSE:ADNT – Free Report).
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.